Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose versus low-dose methylprednisolone to prevent liver failure in severe acute exacerbation of chronic hepatitis B
ChiCTR-TRC-12002257Phase 4Completed
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Jun 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methylprednisolone in Chronic Hepatitis B (CHB) and acute-on-chronic liver failure (ACLF) (3 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: Total bilirubin, Prothrombin time and 4 more. Started Jun 2012; status: completed.
02
Drugs
methylprednisolone
03
Conditions
Chronic Hepatitis B (CHB)acute-on-chronic liver failure (ACLF)
Beyond the preview
Go deeper on ChiCTR-TRC-12002257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002257.